Core Points - The company announced a joint investment with professional investment institutions to establish a partnership for investing in the pet industry chain [1] - The total subscribed capital of the partnership is RMB 406 million, with the company contributing RMB 154 million, accounting for 37.9310% of the total [1] - The partnership has been registered with the Asset Management Association of China and has obtained the Private Investment Fund Registration Certificate [1] Investment Details - The meeting to approve the investment was held on October 13, 2025 [1] - The partnership includes Tianjin Port Free Trade Zone Emerging Industry Development Fund Partnership, Tianjin Lingang Equity Investment Fund Management Co., Ltd., and Mingzhi Hexin (Tianjin) Equity Investment Fund Management Co., Ltd. [1] - The investment aims to target relevant projects within the pet industry [1]

Core Viewpoint - Reap Bio plans to establish a partnership to invest in the pet industry chain, enhancing its competitive edge through collaboration with specialized institutions [1] Group 1: Investment Strategy - Reap Bio aims to expand its layout in the pet industry chain as part of its strategic planning [1] - The company will collaborate with Tianjin Port Free Trade Zone Emerging Industry Development Fund, Tianjin Lingang Equity Investment Fund Management, and Mingzhi Hexin (Tianjin) Equity Investment Fund Management to form a new investment partnership [1] - The total subscribed capital of the partnership is set at RMB 406 million, with Reap Bio contributing RMB 154 million, representing 37.93% of the total [1]

Core Viewpoint - Reap Bio plans to establish a partnership to invest in the pet industry chain, enhancing its competitive edge through collaboration with specialized institutions [1] Group 1: Investment Strategy - Reap Bio aims to expand its layout in the pet industry chain by forming a partnership with Tianjin Port Free Trade Zone Emerging Industry Development Fund, Tianjin Lingang Equity Investment Fund Management, and Mingzhi Hexin (Tianjin) Equity Investment Fund Management [1] - The total subscribed capital for the partnership is set at RMB 406 million, with Reap Bio contributing RMB 154 million, representing 37.9310% of the total [1]

Group 1 - The company, Reap Bio (300119.SZ), announced its intention to invest in the establishment of Tianjin Baorui Equity Investment Partnership (Limited Partnership) for the purpose of investing in the pet industry chain [1] - The total committed capital for the partnership is 406 million yuan, with the company contributing 154 million yuan from its own funds as a limited partner [1]

Core Viewpoint - The company, Reap Bio (300119.SZ), plans to invest in the pet industry by establishing a partnership fund with a total commitment of 406 million yuan, contributing 154 million yuan from its own funds [1] Group 1 - The company is participating in the establishment of Tianjin Baorui Equity Investment Partnership (Limited Partnership) [1] - The total subscribed capital of the partnership is 406 million yuan [1] - The company will act as a limited partner, investing 154 million yuan of its own funds [1]